These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20055128)

  • 81. Recent developments in protein-ligand affinity mass spectrometry.
    Jonker N; Kool J; Irth H; Niessen WM
    Anal Bioanal Chem; 2011 Mar; 399(8):2669-81. PubMed ID: 21058031
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.
    Skoczen SL; Stern ST
    Methods Mol Biol; 2018; 1682():223-239. PubMed ID: 29039106
    [TBL] [Abstract][Full Text] [Related]  

  • 83. On-line sample preparation for high throughput reversed-phase LC/MS analysis of combinatorial chemistry libraries.
    Tang L; Fitch WL; Smith P; Tumelty D; Cao K; Ferla SW
    Comb Chem High Throughput Screen; 2001 May; 4(3):287-93. PubMed ID: 11375743
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Development of a Magnetic Microbead Affinity Selection Screen (MagMASS) Using Mass Spectrometry for Ligands to the Retinoid X Receptor-α.
    Rush MD; Walker EM; Prehna G; Burton T; van Breemen RB
    J Am Soc Mass Spectrom; 2017 Mar; 28(3):479-485. PubMed ID: 27966173
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Affinity ultrafiltration and UPLC-HR-Orbitrap-MS based screening of thrombin-targeted small molecules with anticoagulation activity from Poecilobdella manillensis.
    Huang Q; Tang J; Chai X; Ren W; Wang J; Gan Q; Shi J; Wang M; Yang S; Liu J; Ma L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jul; 1178():122822. PubMed ID: 34147951
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Affinity selection and mass spectrometry-based strategies to identify lead compounds in combinatorial libraries.
    Kaur S; McGuire L; Tang D; Dollinger G; Huebner V
    J Protein Chem; 1997 Jul; 16(5):505-11. PubMed ID: 9246636
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Screening of G-quadruplex ligands from Macleaya cordata extract by contrast ultrafiltration with liquid chromatography-mass spectrometry and molecular docking].
    Gao Y; Qin WW; Ge YW; Sun Y; Yan YS; Zeng Y; Wang F
    Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(16):3908-3914. PubMed ID: 32893588
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mass spectrometry-based strategies for screening of bioactive natural products.
    Xin GZ; Zhou JL; Qi LW; Li P
    Comb Chem High Throughput Screen; 2011 Feb; 14(2):93-103. PubMed ID: 21118084
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluation of a micro volume pulsed ultrafiltration cell for screening ligands in non-covalent complexes.
    Beverly MB; West P; Julian RK
    Comb Chem High Throughput Screen; 2002 Feb; 5(1):65-73. PubMed ID: 11860341
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Characterization of plasma protein binding dissociation with online SPE-HPLC.
    Li P; Fan Y; Wang Y; Lu Y; Yin Z
    Sci Rep; 2015 Oct; 5():14866. PubMed ID: 26460813
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Novel methods for biocatalyst screening.
    Wahler D; Reymond JL
    Curr Opin Chem Biol; 2001 Apr; 5(2):152-8. PubMed ID: 11282341
    [TBL] [Abstract][Full Text] [Related]  

  • 92. LABEL-FREE BIO-AFFINITY MASS SPECTROMETRY FOR SCREENING AND LOCATING BIOACTIVE MOLECULES.
    Tao Y; Yan J; Cai B
    Mass Spectrom Rev; 2021 Jan; 40(1):53-71. PubMed ID: 31755145
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Screening for inhibitors of topoisomerase I from Lycoris radiata by combining ultrafiltration with liquid chromatography/mass spectrometry.
    Chen G; Tian Y; Guo M
    Rapid Commun Mass Spectrom; 2016 Aug; 30 Suppl 1():95-9. PubMed ID: 27539422
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Determining affinity-selected ligands and estimating binding affinities by online size exclusion chromatography/liquid chromatography-mass spectrometry.
    Blom KF; Larsen BS; McEwen CN
    J Comb Chem; 1999 Jan; 1(1):82-90. PubMed ID: 10746016
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Integration of NMR and high-throughput screening.
    Hajduk PJ; Burns DJ
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):613-21. PubMed ID: 12470258
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Screening and Isolation of Potential Anti-Inflammatory Compounds from
    Li G; Fang Y; Ma Y; Dawa Y; Wang Q; Gan J; Dang J
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745138
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Solving the Competitive Binding Equilibria between Many Ligands: Application to High-Throughput Screening and Affinity Optimization.
    Blay V; Otero-Muras I; Annis DA
    Anal Chem; 2020 Sep; 92(18):12630-12638. PubMed ID: 32812419
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Utility of mass spectrometry for pharmaceutical profiling applications.
    Kerns EH; Di L
    Curr Drug Metab; 2006 Jun; 7(5):457-66. PubMed ID: 16787155
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Practical aspects of NMR-based fragment discovery.
    Zartler ER; Mo H
    Curr Top Med Chem; 2007; 7(16):1592-9. PubMed ID: 17979770
    [TBL] [Abstract][Full Text] [Related]  

  • 100. RNA-ALIS: Methodology for screening soluble RNAs as small molecule targets using ALIS affinity-selection mass spectrometry.
    Rizvi NF; Nickbarg EB
    Methods; 2019 Sep; 167():28-38. PubMed ID: 31059829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.